volume 310, issue 9, PF857-F871 2016
DOI: 10.1152/ajprenal.00513.2015
View full text
|
Sign up to set email alerts
|
Share

Abstract: Patients and animals with chronic kidney disease (CKD) exhibit profound alterations in the gut environment including shifts in microbial composition, increased fecal pH, and increased blood levels of gut microbe-derived metabolites (xenometabolites). The fermentable dietary fiber high amylose maize-resistant starch type 2 (HAMRS2) has been shown to alter the gut milieu and in CKD rat models leads to markedly improved kidney function. The aim of the present study was to identify specific cecal bacteria and ceca…

Expand abstract